epigallocatechin gallate has been researched along with Zika Virus Infection in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 2 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bernatchez, JA; Li, J; Li, R; Luan, Y; Siqueira-Neto, JL; Tran, LT | 1 |
| Jha, HC; Mishra, A; Pandey, RK; Patra, P; Prashar, T; Rani, A; Saini, V | 1 |
2 review(s) available for epigallocatechin gallate and Zika Virus Infection
| Article | Year |
|---|---|
Drugs for the Treatment of Zika Virus Infection.
Topics: Animals; Antiviral Agents; Drug Development; Drug Discovery; Humans; Viral Vaccines; Zika Virus; Zika Virus Infection | 2020 |
Epigallocatechin Gallate: A Multifaceted Molecule for Neurological Disorders and Neurotropic Viral Infections.
Topics: Alzheimer Disease; Epstein-Barr Virus Infections; Glycogen Synthase Kinase 3; Herpesvirus 4, Human; Humans; Nervous System Diseases; Phosphatidylinositol 3-Kinases; Zika Virus; Zika Virus Infection | 2023 |